Stock ARYA ARYA SCIENCES ACQUISITION III A
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

ARYA Sciences Acquisition III A Stock

Equities

ARYA

KYG3166W1069

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Chart ARYA Sciences Acquisition III A

Dynamic Chart

Latest news about ARYA Sciences Acquisition III A

ARYA Sciences Acquisition Corp III(NasdaqCM:ARYA) dropped from NASDAQ Composite Index CI
Nautilus Biotechnology, Inc. completed the acquisition of ARYA Sciences Acquisition Corp III in a reverse merger transaction. CI
Arya Sciences Acquisition Corp Iii Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Arya Sciences Acquisition Corp Iii Reports Earnings Results for the Nine Months Ended December 31, 2020 CI
Close Update: US Stocks End With New Highs on Stimulus Support From Yellen, Continued Vaccine Deployment MT
Sector Update: Health Care Stocks Sit Out Monday Markets Rise Despite Biotech Gains MT
Update: Arya Sciences Acquisition III Shares Almost Double After Unveiling Merger Agreement With Nautilus Biotechnology MT
Sector Update: Health Care Stocks Edging Lower Despite Solid Gains for Biotechs MT
US Stocks Advance, Oil Jumps After Treasury Secretary Reinforces Backing for Big US Fiscal Stimulus Plans MT
Midday Report: US Stocks Advance, Oil Jumps After Treasury Secretary Reinforces Backing for Big US Fiscal Stimulus Plans MT
ARYA Sciences Acquisition III : Nautilus Biotechnology to Combine with Blank-Check Firm Arya Sciences MT
DJ Industrial : Wall Street Set for Small Gains, Buoyed by Stimulus Progress MT
Nautilus Biotechnology, Inc. entered into a definitive merger agreement to acquire ARYA Sciences Acquisition Corp III for approximately $1 billion in a reverse merger transaction. CI
Certain Class B Ordinary Shares of ARYA Sciences Acquisition Corp III are subject to a Lock-Up Agreement Ending on 3-FEB-2021. CI
ARYA Sciences Acquisition Corp III announced that it has received $4.99 million in funding from Arya Sciences Holdings III CI
More news

Press releases ARYA Sciences Acquisition III A

ARYA Sciences Acquisition III : Condensed Statements of Redeemable Convertible Preferred Stock and Stockholders’ Deficit for the Three Months Ended March 31, 2021 and 2020 (unaudited) (Form 8-K) PU
NAUTILUS BIOTECHNOLOGY, INC. : Change in Directors or Principal Officers, Amendment or Waiver to Code of Ethics (form 8-K) AQ
ARYA SCIENCES ACQUISITION CORP III : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
ARYA Sciences Acquisition III : Announces Extraordinary General Meeting Teleconference Details (Form 8-K) PU
ARYA SCIENCES ACQUISITION CORP III : Other Events, Financial Statements and Exhibits (form 8-K) AQ
More press releases

Company Profile

ARYA Sciences Acquisition Corp III is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. It intends to focus on entities operating in the healthcare industry, particularly the life sciences and medical technology sectors. It has not commenced any operations.
Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. ARYA Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW